Grant opportunityArchived
Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools to Accelerate Therapeutics Development for Opioid and Stimulant Use Disorders (UG3/UH3 Clinical Trial Optional)
RFA-DA-25-028 · NIH
Grant details are part of the paid plan
Award amounts, eligibility, deadlines, and the application link — plus grant alerts the moment new funding posts.
Create an account →